Startups use CRISPR technology to target epigenetic markers in disease treatment
Several biotechnology startups are utilizing CRISPR systems to modify specific epigenetic marks rather than altering DNA sequences directly. These developments aim to treat conditions such as high cholesterol and a rare muscular disorder.
Amalgamated from Scientific American (opens in new tab), Nature (opens in new tab), Nature (opens in new tab)
A group of startup firms is using CRISPR technology to target epigenetic markers for the treatment of several medical conditions, according to reports from Scientific American and Nature. These companies are testing therapies designed to treat disorders such as high cholesterol and a rare muscular disorder.
The focus on epigenome editing represents a shift in how these tools are applied in medicine. While traditional methods often involve altering DNA sequences directly, targeting epigenetic markers involves modifying chemical signals that control the expression of genes. This approach aims to regulate gene activity without making permanent changes to the underlying genetic code.
Reports from both Scientific American and Nature indicate that this method is being explored as a way to provide more targeted treatments for chronic conditions and rare diseases alike. By focusing on these markers, researchers aim to utilize CRISPR technology in broader ways beyond direct genomic modification.
Why this matters
The use of CRISPR for epigenome editing targets the regulation of gene expression rather than direct genetic modification. This method provides a different pathway for treating conditions where altering the underlying DNA sequence might be undesirable or technically difficult.
What's confirmed / what isn't
Several startups are using CRISPR to target epigenetic markers for high cholesterol and a rare muscular disorder, as reported by both Scientific American and Nature. Specific details regarding the names of these companies or specific clinical trial results were not provided in the source reports.
Background
Epigenetics refers to chemical modifications, such as methylation, that influence how genes are expressed without changing the DNA sequence itself. These marks can turn genes on or off and are influenced by various internal and external factors.